Trials / Recruiting
RecruitingNCT06599957
Innovative Drug Delivery Nanophotonic Platform for Implementation of Sarcoma Therapy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Istituto Ortopedico Rizzoli · Academic / Other
- Sex
- All
- Age
- 2 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
DEEPLY aims to improve sarcoma therapy by the development of an innovative nanophotonic delivery approach to be applied in the future as an integrated local therapy for patients with inoperable tumors or with oligometastases. The major aim of the project is the development of innovative nanocarriers loaded with chemotherapeutic agents, whose delivery will be improved by the use of an optic fiber (optoporation). After the synthesis, and characterization of NPs, a prototype will be produced and preclinically validated on patient-derived biological material. This wide comprehensive methodological approach will ensure the obtainment of robust data to be faster exploited toward clinical applications.
Conditions
Timeline
- Start date
- 2024-08-30
- Primary completion
- 2026-08-30
- Completion
- 2026-08-30
- First posted
- 2024-09-19
- Last updated
- 2025-09-22
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT06599957. Inclusion in this directory is not an endorsement.